Needle-stick injuries, unfortunately, are a common occurrence during blood extraction and handling of specimens in the laboratory, which often lead to the contraction of blood-borne viral diseases. Mycobacterium tuberculosis infection also poses a threat to healthcare workers, especially laboratory workers in areas with endemic levels of tuberculosis infections. We present in this report, a case of primary inoculation of tuberculosis of the skin transmitted following a needle-stick injury, which was successfully treated. Reports of such an occurrence are few, and our report further underlines the need to take greater precautions against these accidents. In addition, our case draws attention to the possibility of prophylactic anti-tuberculous treatment in high-risk patients to prevent the progression of an overt illness.
REFERENCE:
Ghanbar MI, Bukharie HA. Another hazard to laboratory workers. Saudi J Med Med Sci 2015;3:174-7
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
| Lista de correo. Espere su aprobación. |
| Consultar este grupo |
viernes, 5 de abril de 2019
miércoles, 3 de abril de 2019
El hongo destructor de especies

Parece un título exagerado, pero no lo es. Un hongo está erradicando especies de anfibios (ranas, sapos) y salamandras a escala global. Su nombre: Batrachochytrium dendrobatidis, y se calcula que desde 1965, de las 500 especies afectadas por este hongo, 90 especies ya se han extinguido(1). Este hongo es el agente causal de una infección en la piel de los anfibios llamada quitridiomicosis. Y aunque es una enfermedad tratable, en especies silvestres es casi imposible administrar los tratamientos. Es tan grave el asunto que la Oficina Internacional de Epizootías (OIE), de la Organización Mundial de Sanidad animal ha declarado a la enfermedad como de notificación obligatoria por la gran amenaza que representa a la biodiversidad. El término científico es que es una "panzootia", lo que en términos de patógenos humanos sería equivalente a una "pandemia". Al existir una pérdida tan grande en la biodiversidad, B. dendrobatidis se ha convertido en el patógeno con mayor mortalidad en el mundo.
REFERENCIA:
1. Scheele BC, et al. (2019) Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity Science 363(6434):1459–1463.
lunes, 1 de abril de 2019
Gene editing using CRISPR/Cas9: implications for dual-use and #biosecurity
[FRAGMENT...]
We have read with interest the recent paper by Kang, et al (2017), addressing clinical and ethical issues related to the safe and responsible use of CRISPR/Cas. The authors provide a number of important considerations about the current capabilities offered by this novel gene-editing tool, including germ line editing in embryos, and potential diverse uses in adult human applications. The authors posit that the tool in of itself does not represent a threat, and that periodic assessment will ensure its responsible use. We agree, but with caveat: namely, that any tool that imparts great capability also involves at least some risk, if not threat, that the power conferred by such capacity can be used to leverage or evoke a variety of ends. This deviation of intent is a principal concern of dual-use research and its applications.
REFERENCE:
DiEuliis, Diane and James Giordano. “Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity” Protein & cell vol. 9,3 (2017): 239-240.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
We have read with interest the recent paper by Kang, et al (2017), addressing clinical and ethical issues related to the safe and responsible use of CRISPR/Cas. The authors provide a number of important considerations about the current capabilities offered by this novel gene-editing tool, including germ line editing in embryos, and potential diverse uses in adult human applications. The authors posit that the tool in of itself does not represent a threat, and that periodic assessment will ensure its responsible use. We agree, but with caveat: namely, that any tool that imparts great capability also involves at least some risk, if not threat, that the power conferred by such capacity can be used to leverage or evoke a variety of ends. This deviation of intent is a principal concern of dual-use research and its applications.
REFERENCE:
DiEuliis, Diane and James Giordano. “Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity” Protein & cell vol. 9,3 (2017): 239-240.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
viernes, 29 de marzo de 2019
FORO: Prevención integral de infecciones asociadas a la atención a la salud
Atenta invitación.
Cámara de Diputados. Jueves 11 de abril de 2019.
Cupo limitado. Llamar en horarios de oficina
-----------------------------------------------------------
Ayúdanos a traducir las fichas de seguridad de microorganismos.
-----------------------------------------------------------
Amphibian fungal panzootic causes catastrophic loss of biodiversity
Anthropogenic trade and development have broken down dispersal barriers, facilitating the spread of diseases that threaten Earth’s biodiversity. We present a global, quantitative assessment of the amphibian chytridiomycosis panzootic, one of the most impactful examples of disease spread, and demonstrate its role in the decline of at least 501 amphibian species over the past half-century, including 90 presumed extinctions. The effects of chytridiomycosis have been greatest in large-bodied, range-restricted anurans in wet climates in the Americas and Australia. Declines peaked in the 1980s, and only 12% of declined species show signs of recovery, whereas 39% are experiencing ongoing decline. There is risk of further chytridiomycosis outbreaks in new areas. The chytridiomycosis panzootic represents the greatest recorded loss of biodiversity attributable to a disease.
REFERENCE:
Scheele BC et al. Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity. 29 Mar 2019: Vol. 363, Issue 6434, pp. 1459-1463 DOI: 10.1126/science.aav0379
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Scheele BC et al. Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity. 29 Mar 2019: Vol. 363, Issue 6434, pp. 1459-1463 DOI: 10.1126/science.aav0379
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
miércoles, 27 de marzo de 2019
#HIV prevalence in suspected #Ebola en Sierra Leona
BACKGROUND: The 2014-2016 Ebola virus epidemic in West Africa was the largest outbreak of Ebola virus disease (EVD) in history. Clarifying the influence of other prevalent diseases such as human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) will help improve treatment and supportive care of patients with EVD.
CASE PRESENTATION: We examined HIV and hepatitis C virus (HCV) antibody prevalence among suspected EVD cases from the Sierra Leone-China Friendship Biological Safety Laboratory during the epidemic in Sierra Leone. HIV and HCV antibodies were tested in 678 EVD-negative samples by enzyme-linked immunosorbent assay. A high HIV prevalence (17.6%) and low HCV prevalence (0.22%) were observed among the suspected cases. Notably, we found decreased HIV positive rates among the suspected cases over the course of the epidemic. This suggests a potentially beneficial effect of an improved public health system after assistance from the World Health Organization and other international aid organizations.
CONCLUSIONS: This EVD epidemic had a considerable impact on the public health system and influenced the prevalence of HIV found among suspected cases in Sierra Leone, but also provided an opportunity to establish a better surveillance network for infectious diseases.
REFERENCE:
Liu WJ, et al. HIV prevalence in suspected Ebola cases during the 2014-2016 Ebola epidemic in Sierra Leone. Infect Dis Poverty. 2019 Mar 4;8(1):15. doi: 10.1186/s40249-019-0525-9.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
CASE PRESENTATION: We examined HIV and hepatitis C virus (HCV) antibody prevalence among suspected EVD cases from the Sierra Leone-China Friendship Biological Safety Laboratory during the epidemic in Sierra Leone. HIV and HCV antibodies were tested in 678 EVD-negative samples by enzyme-linked immunosorbent assay. A high HIV prevalence (17.6%) and low HCV prevalence (0.22%) were observed among the suspected cases. Notably, we found decreased HIV positive rates among the suspected cases over the course of the epidemic. This suggests a potentially beneficial effect of an improved public health system after assistance from the World Health Organization and other international aid organizations.
CONCLUSIONS: This EVD epidemic had a considerable impact on the public health system and influenced the prevalence of HIV found among suspected cases in Sierra Leone, but also provided an opportunity to establish a better surveillance network for infectious diseases.
REFERENCE:
Liu WJ, et al. HIV prevalence in suspected Ebola cases during the 2014-2016 Ebola epidemic in Sierra Leone. Infect Dis Poverty. 2019 Mar 4;8(1):15. doi: 10.1186/s40249-019-0525-9.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
lunes, 25 de marzo de 2019
Raccoon Rabies Virus Variant Transmission Through Solid Organ Transplantation
Importance: The rabies virus causes a fatal encephalitis and can be transmitted through tissue or organ transplantation. In February 2013, a kidney recipient with no reported exposures to potentially rabid animals died from rabies 18 months after transplantation. Objectives: To investigate whether organ transplantation was the source of rabies virus exposure in the kidney recipient, and to evaluate for and prevent rabies in other transplant recipients from the same donor. Design: Organ donor and all transplant recipient medical records were reviewed. Laboratory tests to detect rabies virus–specific binding antibodies, rabies virus neutralizing antibodies, and rabies virus antigens were conducted on available specimens, including serum, cerebrospinal fluid, and tissues from the donor and the recipients. Viral ribonucleic acid was extracted from tissues and amplified for nucleoprotein gene sequencing for phylogenetic comparisons. Main Outcomes and Measures: Determination of whether the donor died from undiagnosed rabies and whether other organ recipients developed rabies. Results: In retrospect, the donor’s clinical presentation (which began with vomiting and upper extremity paresthesias and progressed to fever, seizures, dysphagia, autonomic dysfunction, and brain death) was consistent with rabies. Rabies virus antigen was detected in archived autopsy brain tissue collected from the donor. The rabies viruses infecting the donor and the deceased kidney recipient were consistent with the raccoon rabies virus variant and were more than 99.9% identical across the entire N gene (1349/1350 nucleotides), thus confirming organ transplantation as the route of transmission. The 3 other organ recipients remained asymptomatic, with rabies virus neutralizing antibodies detected in their serum after completion of postexposure prophylaxis (range, 0.3-40.8 IU/mL). Conclusions and Relevance: Unlike the 2 previous clusters of rabies virus transmission through solid organ transplantation, there was a long incubation period in the recipient who developed rabies, and survival of 3 other recipients without pretransplant rabies vaccination. Rabies should be considered in patients with acute progressive encephalitis of unexplained etiology, especially for potential organ donors. A standard evaluation of potential donors who meet screening criteria for infectious encephalitis should be considered, and risks and benefits for recipients of organs from these donors should be evaluated.
REFERENCE:
Vora NM, Basavaraju SV, Feldman KA, et al. Raccoon Rabies Virus Variant Transmission Through Solid Organ Transplantation. JAMA. 2013;310(4):398–407. doi:10.1001/jama.2013.7986
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Vora NM, Basavaraju SV, Feldman KA, et al. Raccoon Rabies Virus Variant Transmission Through Solid Organ Transplantation. JAMA. 2013;310(4):398–407. doi:10.1001/jama.2013.7986
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
jueves, 21 de marzo de 2019
#24Marzo Día Mundial contra la #Tuberculosis 2019 #EndTB
"Es hora de actuar"
El 24 de marzo de cada año se celebra el Día Mundial de la Tuberculosis para concienciar sobre las terribles consecuencias sociales, económicas y para la salud de la tuberculosis (TB) y acelerar los esfuerzos por poner fin a la epidemia mundial de esta enfermedad. En esta fecha se conmemora el día de 1882 en el que el Dr. Robert Koch anunció que había descubierto la bacteria que provoca la TB, lo que posibilitó diagnosticar y curar la enfermedad.La TB sigue siendo la enfermedad infecciosa más letal del mundo. Cada día mueren casi 4500 personas a causa de la TB y aproximadamente 30 000 personas contraen esta enfermedad prevenible y curable. Se calcula que los esfuerzos mundiales por luchar contra la TB han salvado 54 millones de vidas desde 2000 y han reducido la tasa de mortalidad por TB en un 42%. Para acelerar la respuesta a la TB en los países con el fin de alcanzar las metas, los Jefes de Estado celebraron en septiembre de 2018 la primera Reunión de Alto Nivel de las Naciones Unidas sobre la TB, en la que se comprometieron fehacientemente a poner fin a esta enfermedad.
WEBSITE: https://www.who.int/campaigns/world-tb-day/world-tb-day-2019
ESPAÑOL: https://www.who.int/es/news-room/events/detail/2019/03/24/default-calendar/world-tb-day-2019
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
Bioaerosols and Transmission, a Diverse and Growing Community of Practice
The transmission of infectious microbes via bioaerosols is of significant concern for both human and animal health. However, gaps in our understanding of respiratory pathogen transmission and methodological heterogeneity persist. New developments have enabled progress in this domain, and one of the major turning points has been the recognition that cross-disciplinary collaborations across spheres of human and animal health, microbiology, biophysics, engineering, aerobiology, infection control, public health, occupational health, and industrial hygiene are essential. Collaborative initiatives support advances in topics such as bioaerosol behavior, dispersion models, risk assessment, risk/exposure effects, and mitigation strategies in clinical, experimental, agricultural, and other field settings. There is a need to enhance the knowledge translation for researchers, stakeholders, and private partners to support a growing network of individuals and agencies to achieve common goals to mitigate inter- and intra-species pathogen transmission via bioaerosols.
REFERENCE:
Mubareka S, et al. Bioaerosols and Transmission, a Diverse and Growing Community of Practice. Front Public Health. 2019 Feb 21;7:23. doi: 10.3389/fpubh.2019.00023. eCollection 2019. Review.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Mubareka S, et al. Bioaerosols and Transmission, a Diverse and Growing Community of Practice. Front Public Health. 2019 Feb 21;7:23. doi: 10.3389/fpubh.2019.00023. eCollection 2019. Review.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
lunes, 18 de marzo de 2019
Plants Developed by New Genetic Modification Techniques
The development of new genetic modification techniques (nGMs), also referred to as "new (breeding) techniques" in other sources, has raised worldwide discussions regarding their regulation. Different existing regulatory frameworks for genetically modified organisms (GMO) cover nGMs to varying degrees. Coverage of nGMs depends mostly on the regulatory trigger. In general two different trigger systems can be distinguished, taking into account either the process applied during development or the characteristics of the resulting product. A key question is whether regulatory frameworks either based on process- or product-oriented triggers are more advantageous for the regulation of nGM applications. We analyzed regulatory frameworks for GMO from different countries covering both trigger systems with a focus on their applicability to plants developed by various nGMs. The study is based on a literature analysis and qualitative interviews with regulatory experts and risk assessors of GMO in the respective countries. The applied principles of risk assessment are very similar in all investigated countries independent of the applied trigger for regulation. Even though the regulatory trigger is either process- or product-oriented, both triggers systems show features of the respective other in practice. In addition our analysis shows that both trigger systems have a number of generic advantages and disadvantages, but neither system can be regarded as superior at a general level. More decisive for the regulation of organisms or products, especially nGM applications, are the variable criteria and exceptions used to implement the triggers in the different regulatory frameworks. There are discussions and consultations in some countries about whether changes in legislation are necessary to establish a desired level of regulation of nGMs. We identified five strategies for countries that desire to regulate nGM applications for biosafety-ranging from applying existing biosafety frameworks without further amendments to establishing new stand-alone legislation. Due to varying degrees of nGM regulation, international harmonization will supposedly not be achieved in the near future. In the context of international trade, transparency of the regulatory status of individual nGM products is a crucial issue. We therefore propose to introduce an international public registry listing all biotechnology products commercially used in agriculture.
REFERENCE:
Eckerstorfer MF, et al. Plants Developed by New Genetic Modification Techniques-Comparison of Existing Regulatory Frameworks in the EU and Non-EU Countries. Front Bioeng Biotechnol. 2019 Feb 19;7:26. doi: 10.3389/fbioe.2019.00026. eCollection 2019.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Eckerstorfer MF, et al. Plants Developed by New Genetic Modification Techniques-Comparison of Existing Regulatory Frameworks in the EU and Non-EU Countries. Front Bioeng Biotechnol. 2019 Feb 19;7:26. doi: 10.3389/fbioe.2019.00026. eCollection 2019.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
jueves, 14 de marzo de 2019
#España: Plan Nacional de Biocustodia
El Consejo de Seguridad Nacional, en su reunión del día 21 de enero de 2019, ha
aprobado el Plan Nacional de Biocustodia. La Estrategia de Seguridad Nacional, aprobada por Acuerdo del Consejo de Ministros del 31 de mayo de 2013, incluyó la adopción de un «Plan Nacional de Biocustodia» entre sus objetivos. Por su parte, la Estrategia de Seguridad Nacional de 2017 incluye entre los suyos «el combatir la proliferación de armas de destrucción masiva, sus vectores de lanzamiento, materiales conexos y tecnología asociada, así como impedir su acceso a actores no estatales, y en particular a organizaciones terroristas». Para lograr este Objetivo establece como línea de acción el «fortalecer las capacidades nacionales en el área de la no proliferación mediante la aplicación de la normativa internacional y el desarrollo y actualización de la normativa nacional».
REFERENCIA:
2553 Orden PCI/168/2019, de 22 de febrero, por la que se publica el Plan Nacional de Biocustodia, aprobado por el Consejo de Seguridad Nacional.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCIA:
2553 Orden PCI/168/2019, de 22 de febrero, por la que se publica el Plan Nacional de Biocustodia, aprobado por el Consejo de Seguridad Nacional.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
miércoles, 13 de marzo de 2019
#OpenWHO
OpenWHO is WHO’s new interactive, web-based, knowledge-transfer platform offering online courses to improve the response to health emergencies. OpenWHO enables the Organization and its key partners to transfer life-saving knowledge to large numbers of frontline responders.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
lunes, 11 de marzo de 2019
Surrogate strains of human pathogens for field release
Surrogate microorganisms, in short surrogates, are an essential part of pathogen research. Compared to surrogates used in controlled laboratory environments, surrogates for field release are restricted by concerns about human and environmental safety. For field research of food-borne pathogens, strains of an attenuated pathogen or strains of genetically close non-pathogenic species have been used as surrogates. Genetic modification is usually performed to attenuate virulence, through for examples deletion of genes of virulence and transcriptional regulators and removal of virulence plasmids, and to facilitate detection and monitoring through observing antibiotic resistance, fluorescence, and bioluminescence. For field research of a biological warfare agent Bacillus anthracis, strains of genetically close non-pathogenic species or strains of genetically distant non-pathogenic species have been used, mostly without any genetic modification. Recently, we constructed strains of Bacillus thuringiensis as surrogates for B. anthracis, demonstrating that strain engineering could significantly enhance the utility of surrogates, and that the application of a simple genetic circuit could significantly impact surrogate safety. Thus far, enormous potential of biotechnology has not been exploited enough due to safety concerns regarding the field release of genetically engineered microorganisms. However, synthetic biology is rapidly developing, providing new concepts for biocontainment as well as ingenious genetic circuits and devices, which should be applied in future research of field-use surrogates.
REFERENCE:
Park S, Kim CH, Jeong ST, Lee SY. Surrogate strains of human pathogens for field release. Bioengineered. 2018 Jan 1;9(1):17-24. doi: 10.1080/21655979.2017.1349044. Epub 2017 Jul 26. Review.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Park S, Kim CH, Jeong ST, Lee SY. Surrogate strains of human pathogens for field release. Bioengineered. 2018 Jan 1;9(1):17-24. doi: 10.1080/21655979.2017.1349044. Epub 2017 Jul 26. Review.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
viernes, 8 de marzo de 2019
Prevención y control de infecciones asociadas a la atención de la salud
Según la evidencia científica disponible, las intervenciones con mejores resultados son aquellas cuyas prácticas solo se admiten si se realizan de forma correcta, que a menudo requiere cambios estructurales y culturales de los equipos de salud. Cuando tales intervenciones no sean factibles, es necesario establecer y asegurar el cumplimiento de medidas que permitan modificar las conductas del equipo de salud y en las que se pueda mantener adherencia sostenida en el tiempo y que puedan demostrar eficacia a largo plazo.
REFERENCE:
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
DESCARGA: >> ESPAÑOL<< | ENGLISH
Organización Panamericana de la Salud. Prevención y control de infecciones asociadas a la atención de la salud. Recomendaciones Básicas. Washington, D.C. : OPS : 2017Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
miércoles, 6 de marzo de 2019
LIBRO: Epidemiología básica
Este texto es una introducción a los principios y métodos básicos de la epidemiología. Está destinado a un público amplio de profesionales de las ciencias de la salud y de las ciencias ambientales que participan en cursos de formación práctica, así como estudiantes de medicina y de otras profesiones sanitarias u otras materias que precisen conocimientos epidemiológicos. La terminología utilizada se basa fundamentalmente en el diccionario de epidemiología de Last (1995). Los objetivos de esta Epidemiología básica son:
• explicar los principios del proceso causal de las enfermedades, subrayando la importancia de los factores ambientales modificables;
• estimular la aplicación de la epidemiología a la prevención de la enfermedad y la promoción de la salud, incluida la higiene ambiental y la salud laboral;
• preparar a los profesionales de la salud para enfrentar las necesidades crecientes de cobertura de todos los aspectos de la salud de las poblaciones, garantizando el mejor uso posible de los recursos en los servicios de salud;
• estimular la buena práctica clínica mediante la introducción de los conceptos de la epidemiología clínica;
• favorecer permanentemente el interés en la epidemiología.
REFERENCIA:
DESCARGA1 | DESCARGA2
Epidemiología básica / Robert Beaglehole, Ruth Bonita, Tord Kjellstróm. - Washington, D.C.: OPS, © 1994 (Publicación Científica ; 551) ISBN 92 75 31551 5
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
• explicar los principios del proceso causal de las enfermedades, subrayando la importancia de los factores ambientales modificables;
• estimular la aplicación de la epidemiología a la prevención de la enfermedad y la promoción de la salud, incluida la higiene ambiental y la salud laboral;
• preparar a los profesionales de la salud para enfrentar las necesidades crecientes de cobertura de todos los aspectos de la salud de las poblaciones, garantizando el mejor uso posible de los recursos en los servicios de salud;
• estimular la buena práctica clínica mediante la introducción de los conceptos de la epidemiología clínica;
• favorecer permanentemente el interés en la epidemiología.
REFERENCIA:
DESCARGA1 | DESCARGA2
Epidemiología básica / Robert Beaglehole, Ruth Bonita, Tord Kjellstróm. - Washington, D.C.: OPS, © 1994 (Publicación Científica ; 551) ISBN 92 75 31551 5
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
lunes, 4 de marzo de 2019
Disinfectant exposure among staff at a large multispecialty hospital
An interviewer-administered questionnaire on work and health characteristics was completed by 163 current staff. Symptoms that improved away from work were considered work-related. Forty-nine air samples were taken for hydrogen peroxide, peracetic acid, and acetic acid. Prevalence ratios (PRs) were calculated using Poisson regression, and standardized morbidity ratios (SMRs) were calculated using nationally representative data.
Product users reported higher prevalence of work-related wheeze and watery eyes than non-users (P < .05). Workers in the department with the highest air measurements had significantly higher prevalence of watery eyes (PR, 2.88; 95% confidence interval [CI], 1.18–7.05) than those in departments with lower air measurements, and they also had a >3-fold excess of current asthma (SMR, 3.47; 95% CI, 1.48–8.13) compared with the U.S. population.
This disinfectant product was associated with mucous membrane and respiratory health effects. Risks of mucous membrane irritation and asthma in health care workers should be considered in development of disinfection protocols to protect patients from hospital-acquired infections. Identification of optimal protocols that reduce worker exposures while maintaining patient safety is needed.
REFERENCE:
Casey, Megan L et al. “Health problems and disinfectant product exposure among staff at a large multispecialty hospital” American journal of infection control vol. 45,10 (2017): 1133-1138.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
miércoles, 27 de febrero de 2019
Fundamental Techniques in Cell Culture
In partnership with Sigma-Aldrich, ECACC have produced a third edition of ‘Fundamental Techniques in Cell Culture’. This compact laboratory handbook provides a wealth of information from the sourcing of cell lines, safety and laboratory design to aspects of cryopreservation and quality control. A series of 10 detailed protocols are provided, which are routinely used in the ECACC laboratories along with detailed protocols from the European Bank for induced Pluripotent Stem Cells (EBiSC) on how to culture and freeze induced pluripotent cell (iPSC) lines.
REFERENCE:
Fundamental Techniques in Cell Culture, Laboratory Handbook -Third Edition
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Fundamental Techniques in Cell Culture, Laboratory Handbook -Third Edition
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
lunes, 25 de febrero de 2019
Strain, disinfectant, concentration, and contact time quantitatively impact disinfectant efficacy
Transmission of healthcare-associated infections caused by antibiotic- and multi-drug resistant (MDR) pathogens (e.g. Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa) are a major concern in patient care facilities. Disinfectant usage is critical to control and prevent pathogen transmission, yet the relationships among strain, disinfectant type, contact time, and concentration are not well-characterized. We hypothesized that there would be significant differences in disinfectant efficacy among clinically relevant strains under off-label disinfectant conditions, but there would be less no differences among at registered label use concentrations and contact times. The purpose of this study was to quantify the effect of disinfectant concentration and contact time on the bactericidal efficacy of clinically relevant strains of S. aureus and P. aeruginosa.
Accelerated hydrogen peroxide (AHP), quaternary ammonium compounds (Quat), and sodium hypochlorite were tested at label and reduced contact times and concentrations against four MDR P. aeruginosa strains and four MRSA strains. Quantitative EPA method MB-25-02 was used to measure disinfectant efficacy reported as log10 reduction.
Both off-label disinfectant concentrations and contact times significantly affected efficacy of all disinfectants tested. Bactericidal efficacy varied among MRSA and P. aeruginosa strains.
The quantitative disinfectant efficacy method used highlights the inter-strain variability that exists within a bacterial species. It also underscores the need for a disinfectant validation method that takes these variances into account.
REFERENCE:
West, Alyssa M et al. “Strain, disinfectant, concentration, and contact time quantitatively impact disinfectant efficacy” Antimicrobial resistance and infection control vol. 7 49. 3 Apr. 2018, doi:10.1186/s13756-018-0340-2
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
Accelerated hydrogen peroxide (AHP), quaternary ammonium compounds (Quat), and sodium hypochlorite were tested at label and reduced contact times and concentrations against four MDR P. aeruginosa strains and four MRSA strains. Quantitative EPA method MB-25-02 was used to measure disinfectant efficacy reported as log10 reduction.
Both off-label disinfectant concentrations and contact times significantly affected efficacy of all disinfectants tested. Bactericidal efficacy varied among MRSA and P. aeruginosa strains.
The quantitative disinfectant efficacy method used highlights the inter-strain variability that exists within a bacterial species. It also underscores the need for a disinfectant validation method that takes these variances into account.
REFERENCE:
West, Alyssa M et al. “Strain, disinfectant, concentration, and contact time quantitatively impact disinfectant efficacy” Antimicrobial resistance and infection control vol. 7 49. 3 Apr. 2018, doi:10.1186/s13756-018-0340-2
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
miércoles, 20 de febrero de 2019
Laboratory management of Crimean-Congo haemorrhagic fever virus infections
Background: Crimean-Congo haemorrhagic fever virus (CCHFV) is considered an emerging infectious disease threat in the European Union. Since 2000, the incidence and geographic range of confirmed CCHF cases have markedly increased, following changes in the distribution of its main vector, Hyalomma ticks. Aims: To review scientific literature and collect experts' opinion to analyse relevant aspects of the laboratory management of human CCHF cases and any exposed contacts, as well as identify areas for advancement of international collaborative preparedness and laboratory response plans. Methods: We conducted a literature review on CCHF molecular diagnostics through an online search. Further, we obtained expert opinions on the key laboratory aspects of CCHF diagnosis. Consulted experts were members of two European projects, EMERGE (Efficient response to highly dangerous and emerging pathogens at EU level) and EVD-LabNet (Emerging Viral Diseases-Expert Laboratory Network).Results: Consensus was reached on relevant and controversial aspects of CCHF disease with implications for laboratory management of human CCHF cases, including biosafety, diagnostic algorithm and advice to improve lab capabilities. Knowledge on the diffusion of CCHF can be obtained by promoting syndromic approach to infectious diseases diagnosis and by including CCHFV infection in the diagnostic algorithm of severe fevers of unknown origin. Conclusion: No effective vaccine and/or therapeutics are available at present so outbreak response relies on rapid identification and appropriate infection control measures. Frontline hospitals and reference laboratories have a crucial role in the response to a CCHF outbreak, which should integrate laboratory, clinical and public health responses.
REFERENCE:
Bartolini B, et al. Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks. Euro Surveill. 2019 Jan;24(5). doi: 10.2807/1560-7917.ES.2019.24.5.1800093. PubMed PMID: 30722811.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Bartolini B, et al. Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks. Euro Surveill. 2019 Jan;24(5). doi: 10.2807/1560-7917.ES.2019.24.5.1800093. PubMed PMID: 30722811.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
lunes, 18 de febrero de 2019
COMUNICADO AMEXBIO
La AMEXBIO emitió un comunicado sobre la nueva iniciativa de Ley de de Humanidades, Ciencias y Tecnologías. Pueden descargar el documento desde la página: www.amexbio.org-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
Bactericidal efficacy of ready-to-use disinfectant Towelettes
Disinfectant products are often used on environmental surfaces (e.g. countertops, patient beds) and patient care equipment in healthcare facilities to help prevent the transmission of healthcare-associated infections. Ready-to-use (RTU) disinfectants in the form of pre-wetted towelettes are increasingly popular among healthcare facilities. Currently, the EPA does not require disinfectant manufacturers to include a recommended maximum surface area per towelette on their product labels. The objective of this study was to investigate the efficacy of disinfectant towelette products on a hard non-porous surface across different coverage areas using a quantitative EPA method. We hypothesized that there would be significant differences in the efficacy of disinfectant towelette products, and that the greater surface area(s) wiped would result in reduced bactericidal efficacy.
This study tested ten disinfectant towelette products against Staphylococcus aureus strain ATCC CRM-6538 and Pseudomonas aeruginosa strain ATCC 15442 on Formica surfaces. Defined surface areas were wiped and the towelette weighed before and after wiping to determine the amount of liquid released. Bactericidal efficacy testing was also performed after wiping following standard EPA protocols.
REFERENCE:
West, Alyssa M et al. “Surface area wiped, product type, and target strain impact bactericidal efficacy of ready-to-use disinfectant Towelettes” Antimicrobial resistance and infection control vol. 7 122. 11 Oct. 2018, doi:10.1186/s13756-018-0416-z
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
This study tested ten disinfectant towelette products against Staphylococcus aureus strain ATCC CRM-6538 and Pseudomonas aeruginosa strain ATCC 15442 on Formica surfaces. Defined surface areas were wiped and the towelette weighed before and after wiping to determine the amount of liquid released. Bactericidal efficacy testing was also performed after wiping following standard EPA protocols.
REFERENCE:
West, Alyssa M et al. “Surface area wiped, product type, and target strain impact bactericidal efficacy of ready-to-use disinfectant Towelettes” Antimicrobial resistance and infection control vol. 7 122. 11 Oct. 2018, doi:10.1186/s13756-018-0416-z
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
viernes, 15 de febrero de 2019
Synthetic viruses - Anything new?
FRAGMENT: The report of the construction of an infectious horsepox virus from synthesized DNA by Noyce, Lederman, and Evans [1] raised considerable concerns about whether this study will facilitate the construction of smallpox virus (variola) using synthetic biology [2–5]. This is a valid concern, but for a number of reasons—as explained below—no major change concerning the likelihood of a “resurrection” of smallpox emerges from this publication. Having said this, it is also evident that the scientific community, politicians, decision makers, and the lay public have to continue, and probably intensify, a discussion on benefits and risks of synthetic biology in a broader sense.
REFERENCE:
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Thiel V. Synthetic viruses-Anything new? PLoS Pathog. 2018 Oct4;
14(10):e1007019. doi: 10.1371/journal.ppat.1007019. eCollection 2018 Oct.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
miércoles, 13 de febrero de 2019
Biosafety Guidelines
Biosafety guidelines are a set of policies, rules, and procedures necessary to observe by personnel working in various facilities handling microbiological agents such as bacteria, viruses, parasites, fungi, prions, and other related agents and microbiological products. Institutions requiring strict adherence to these biosafety guidelines include clinical and microbiological laboratories, biomedical research facilities, teaching and training laboratories and other healthcare institutions (e.g., clinics, health centers, hospital facilities). These guidelines are intended to provide proper management and regulation of biosafety programs and practices implemented at all levels of the organization. Essential components of the biosafety guidelines contain some or all the following, depending on the facility: microbiological risk assessment and identification; specific biosafety measures, which cover the code of practice, physical plant such as laboratory design and facilities, equipment acquisition and maintenance, medical surveillance, staff training, safe handling of chemicals, with fire, radiation and electricity safety, among others. Additional components may be included such as commissioning and certification guidelines for the facilities. Biosafety guidelines must be made clear, practical and suitable for each facility and must be available for easy reference by all staff, must be reviewed, and updated regularly. While it provides guidance in the application of biosafety practices, this technical guide cannot solely ensure a safe working environment without the commitment of each person to adhere adequately to the biosafety guidelines at all times. Continuous research on biosafety can improve the development of future guidelines[1]
REFERENCE:
Bayot ML, Limaiem F. Biosafety Guidelines. 2019 Jan 31. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. PubMed PMID: 30725895.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Bayot ML, Limaiem F. Biosafety Guidelines. 2019 Jan 31. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. PubMed PMID: 30725895.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
lunes, 11 de febrero de 2019
Study of Disinfectant Resistance Genes of Pseudomonas aeruginosa
Background: The prevalence of disinfectant resistance in Pseudomonas aeruginosa is on the rise. P. aeruginosa is the most common bacteria isolated from cases of microbial keratitis. Many multi-purpose contact lens disinfectant solutions are available to decontaminate contact lenses before use and to help reduce the incidence of infections. However, with increasing disinfectant resistance, the effect of multi-purpose disinfectant solutions may diminish. The goal of this study was to examine genes associated with disinfectant resistance in ocular isolates of P. aeruginosa and understand the strain’s susceptibility to different multipurpose disinfectant solutions. Methods: Seven potential disinfectant resistance genes were used in BLASTn searches against the whole genomes of 13 eye isolates of P. aeruginosa. A microdilution broth method was used to examine susceptibility to four different multipurpose disinfectant solutions. Results: All strains possessed the sugE2, sugE3 and emrE (qacE) genes. The sugE1 and qacEdelta1 genes were present in 6/13 isolates. No strains contained the qacF or qacG genes. All tested disinfectant solutions had the ability to kill all test strains at 100% concentration, with some strains being susceptible at 1:8 dilutions of the disinfecting solutions. However, the presence of disinfectant resistance genes was not associated with susceptibility to multi-purpose disinfectants. Conclusion: All four tested contact lens disinfectant preparations are effective against P. aeruginosa isolates regardless of the presence of disinfectant resistance genes.
REFERENCE:
Subedi, Dinesh et al. “Study of Disinfectant Resistance Genes in Ocular Isolates of Pseudomonas aeruginosa” Antibiotics (Basel, Switzerland) vol. 7,4 88. 15 Oct. 2018, doi:10.3390/antibiotics7040088
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Subedi, Dinesh et al. “Study of Disinfectant Resistance Genes in Ocular Isolates of Pseudomonas aeruginosa” Antibiotics (Basel, Switzerland) vol. 7,4 88. 15 Oct. 2018, doi:10.3390/antibiotics7040088
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
jueves, 7 de febrero de 2019
Protective Gloves and Gowns for Antineoplastic drugs
Background: Many antineoplastic (chemotherapeutic) drugs are known or probable human carcinogens, and many have been shown to be reproductive toxicants in cancer patients. Evidence from occupational exposure studies suggests that health care workers who have long-term, low-level occupational exposure to antineoplastic drugs have an increased risk of adverse reproductive outcomes. It's recommended that, at minimum, nurses who handle or administer such drugs should wear double gloves and a nonabsorbent gown to protect themselves. But it's unclear to what extent nurses do. Purpose: This study assessed glove and gown use by female pregnant and nonpregnant nurses who administer antineoplastic drugs in the United States and Canada. Methods: We used data collected from more than 40,000 nurses participating in the Nurses’ Health Study 3. The use of gloves and gowns and administration of antineoplastic drugs within the past month (among nonpregnant nurses) or within the first 20 weeks of pregnancy (among pregnant nurses) were self-reported via questionnaire. Results: Administration of antineoplastic drugs at any time during their career was reported by 36% of nonpregnant nurses, including 27% who reported administering these drugs within the past month. Seven percent of pregnant nurses reported administering antineoplastic drugs during the first 20 weeks of pregnancy. Twelve percent of nonpregnant nurses and 9% of pregnant nurses indicated that they never wore gloves when administering antineoplastic drugs, and 42% of nonpregnant nurses and 38% of pregnant nurses reported never using a gown. The percentage of nonpregnant nurses who reported not wearing gloves varied by type of administration: 32% of those who administered antineoplastic drugs only as crushed pills never wore gloves, compared with 5% of those who administered such drugs only via infusion. Conclusion: Despite longstanding recommendations for the safe handling of antineoplastic and other hazardous drugs, many nurses—including those who are pregnant—reported not wearing protective gloves and gowns, which are considered the minimum protective equipment when administering such drugs. These findings underscore the need for further education and training to ensure that both employers and nurses understand the risks involved and know which precautionary measures will minimize such exposures.
REFERENCE:
Lawson, Christina C., et al. Antineoplastic Drug Administration by Pregnant and Nonpregnant Nurses. An Exploration of the Use of Protective Gloves and Gowns. AJN The American Journal of Nursing: January 2019 - Volume 119 - Issue 1 - p 28–35
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
REFERENCE:
Lawson, Christina C., et al. Antineoplastic Drug Administration by Pregnant and Nonpregnant Nurses. An Exploration of the Use of Protective Gloves and Gowns. AJN The American Journal of Nursing: January 2019 - Volume 119 - Issue 1 - p 28–35
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
Ayúdanos a traducir las fichas de seguridad de microorganismos.
www.seguridadbiologica.blogspot.com
-----------------------------------------------------------
Suscribirse a:
Entradas (Atom)






















